HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn2+ from nucleocapsid protein

Virology

Volumn 375, Issue 1, 2008, Pages 148-158

  Morcock, David R ^a   Thomas, James A ^a   Sowder II, Raymond C ^a   Henderson, Louis E ^a   Crise, Bruce J ^a   Gorelick, Robert J ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

HIV 1; Nucleocapsid; Provirus; Reverse transcription; Sulfhydryl reagents; Zinc finger

Indexed keywords

4 VINYLPYRIDINE; CYSTEINE; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; NUCLEOCAPSID PROTEIN; THIOL REAGENT; VIRUS DNA; ZINC;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVIRUS; REVERSE TRANSCRIPTION; VIRUS INFECTION; VIRUS INFECTIVITY;

ANTI-HIV AGENTS; CELL LINE; ETHYLENEDIAMINES; HIV-1; HUMANS; NUCLEOCAPSID PROTEINS; PYRIDINES; VIRUS INACTIVATION; ZINC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 43049092609     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.01.045     Document Type: Article

References (73)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
2. Anderegg G., Hubmann E., Podder N.G., and Wenk F. Pyridinderivate als komplexbildner. XI. Die thermodynamik der metallkomplexbildung mit bis-, tris- und tetrakis[(2-pyridyl)methyl]-aminen. Helv. Chim. Acta 60 (1977) 123-140
3. 2+. J. Biol. Chem. 260 (1985) 2719-2727
4. Berg J.M. Potential metal-binding domains in nucleic acid binding proteins. Science 232 (1986) 485-487
5. Bess Jr. J.W., Powell P.J., Issaq H.J., Schumack L., Grimes M.K., Henderson L.E., and Arthur L.O. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses. J. Virol. 66 (1992) 840-847
6. Bischerour J., Leh H., Deprez E., Brochon J.C., and Mouscadet J.F. Disulfide-linked integrase oligomers involving C280 residues are formed in vitro and in vivo but are not essential for human immunodeficiency virus replication. J. Virol. 77 (2003) 135-141
7. 2+ fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 77 (2003) 1469-1480
8. Burns J.C., Friedmann T., Driever W., Burrascano M., and Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8033-8037
9. Butler S.L., Hansen M.S., and Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7 (2001) 631-634
10. 2+-dependent DNA integration in vitro. J. Virol. 71 (1997) 6225-6229
11. Carteau S., Gorelick R.J., and Bushman F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 73 (1999) 6670-6679
12. Chance M.R., Sagi I., Wirt M.D., Frisbie S.M., Scheuring E., Chen E., Bess Jr. J.W., Henderson L.E., Arthur L.O., South T.L., Perez-Alvarado G., and Summers M.F. Extended X-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10041-10045
13. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess Jr. J.W., Sowder II R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., and Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80 (2006) 9039-9052
14. Chertova E., Crise B.J., Morcock D.R., Bess Jr. J.W., Henderson L.E., and Lifson J.D. Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins. Curr. Mol. Med. 3 (2003) 265-272
15. Chertova E.N., Kane B.P., McGrath C., Johnson D.G., Sowder II R.C., Arthur L.O., and Henderson L.E. Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide. Biochemistry 37 (1998) 17890-17897
16. Covey S.N. Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus. Nucleic Acids Res. 14 (1986) 623-633
17. De Guzman R.N., Wu Z.R., Stalling C.C., Pappalardo L., Borer P.N., and Summers M.F. Structure of the HIV-1 nucleocapsid protein bound to the SL3 Y-RNA recognition element. Science 279 (1998) 384-388
18. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
19. Dvorin J.D., and Malim M.H. Intracellular trafficking of HIV-1 cores: journey to the center of the cell. Curr. Top. Microbiol. Immunol. 281 (2003) 179-208
20. Ellison V., Gerton J., Vincent K.A., and Brown P.O. An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer. J. Biol. Chem. 270 (1995) 3320-3326
21. Engelman A., Englund G., Orenstein J.M., Martin M.A., and Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69 (1995) 2729-2736
22. Fisher R.J., Fivash M.J., Stephen A.G., Hagan N.A., Shenoy S.R., Medaglia M.V., Smith L.R., Worthy K.M., Simpson J.T., Shoemaker R., McNitt K.L., Johnson D.G., Hixson C.V., Gorelick R.J., Fabris D., Henderson L.E., and Rein A. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res. 34 (2006) 472-484
23. Fisher R.J., Rein A., Fivash M., Urbaneja M.A., Casas-Finet J.R., Medaglia M., and Henderson L.E. Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J. Virol. 72 (1998) 1902-1909
24. Friedman M. Application of the S-pyridylethylation reaction to the elucidation of the structures and functions of proteins. J. Protein Chem. 20 (2001) 431-453
25. Friedman M., Krull L.H., and Cavins J.F. The chromatographic determination of cystine and cysteine residues in proteins as S-b-(4-pyridylethyl)cysteine. J. Biol. Chem. 245 (1970) 3868-3871
26. Goff S.P. Host factors exploited by retroviruses. Nat. Rev., Microbiol. 5 (2007) 253-263
27. Gorelick R.J., Chabot D.J., Rein A., Henderson L.E., and Arthur L.O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67 (1993) 4027-4036
28. Gorelick R.J., Gagliardi T.D., Bosche W.J., Wiltrout T.A., Coren L.V., Chabot D.J., Lifson J.D., Henderson L.E., and Arthur L.O. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 256 (1999) 92-104
29. Gorelick R.J., Henderson L.E., Hanser J.P., and Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 8420-8424
30. Gorelick R.J., Nigida Jr. S.M., Bess Jr. J.W., Arthur L.O., Henderson L.E., and Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64 (1990) 3207-3211
31. Guo J., Wu T., Kane B.F., Johnson D.G., Henderson L.E., Gorelick R.J., and Levin J.G. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 76 (2002) 4370-4378
32. Hargittai M.R., Gorelick R.J., Rouzina I., and Musier-Forsyth K. Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site. J. Mol. Biol. 337 (2004) 951-968
33. Hathout Y., Fabris D., Han M.S., Sowder II R.C., Henderson L.E., and Fenselau C. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein p7. Drug Metab. Dispos. 24 (1996) 1395-1400
34. Henderson L.E., Copeland T.D., Sowder R.C., Schultz A.M., and Oroszlan S. Analysis of Proteins and Peptides Purified from Sucrose Gradient Banded HTLV-III, Human Retroviruses, Cancer and AIDS: Approaches to Prevention and Therapy (1988), Alan R. Liss, Inc. 135-147
35. Henderson L.E., Copeland T.D., Sowder II R.C., Smythers G.W., and Oroszlan S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256 (1981) 8400-8406
36. Huang M., Maynard A., Turpin J.A., Graham L., Janini G.M., Covell D.G., and Rice W.G. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins. J. Med. Chem. 41 (1998) 1371-1381
37. Huang Y., Khorchid A., Gabor J., Wang J., Li X., Darlix J.L., Wainberg M.A., and Kleiman L. The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA3Lys genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1. J. Virol. 72 (1998) 3907-3915
38. Julias J.G., Ferris A.L., Boyer P.L., and Hughes S.H. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J. Virol. 75 (2001) 6537-6546
39. Lee B.M., De Guzman R.N., Turner B.G., Tjandra N., and Summers M.F. Dynamical behavior of the HIV-1 nucleocapsid protein. J. Mol. Biol. 279 (1998) 633-649
40. Levin J.G., Guo J., Rouzina I., and Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol. 80 (2005) 217-286
41. Lifson J.D., Rossio J.L., Piatak Jr. M., Bess Jr. J., Chertova E., Schneider D.K., Coalter V.J., Poore B., Kiser R.F., Imming R.J., Scarzello A.J., Henderson L.E., Alvord W.G., Hirsch V.M., Benveniste R.E., and Arthur L.O. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. AIDS Res. Hum. Retrov. 20 (2004) 772-787
42. Lu R., Limon A., Devroe E., Silver P.A., Cherepanov P., and Engelman A. Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J. Virol. 78 (2004) 12735-12746
43. Lu W., Arraes L.C., Ferreira W.T., and Andrieu J.M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10 (2004) 1359-1365
44. Masuda T., Planelles V., Krogstad P., and Chen I.S. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69 (1995) 6687-6696
45. Maynard A.T., Huang M., Rice W.G., and Covell D.G. Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11578-11583
46. Mély Y., De Rocquigny H., Morellet N., Roques B.P., and Gérard D. Zinc binding to the HIV-1 nucleocapsid protein: a thermodynamic investigation by fluorescence spectroscopy. Biochemistry 35 (1996) 5175-5182
47. Morcock D.R., Thomas J.A., Gagliardi T.D., Gorelick R.J., Roser J.D., Chertova E.N., Bess Jr. J.W., Ott D.E., Sattentau Q.J., Frank I., Pope M., Lifson J.D., Henderson L.E., and Crise B.J. Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins. J. Virol. 79 (2005) 1533-1542
48. Ott D.E. Potential roles of cellular proteins in HIV-1. Rev. Med. Virol. 12 (2002) 359-374
49. Ott, D.E., in press. Cellular proteins detected in HIV-1. Rev. Med. Virol. doi:10.1002/rmv.570.
50. Ott D.E., Chertova E.N., Busch L.K., Coren L.V., Gagliardi T.D., and Johnson D.G. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6Gag protein produces a mutant that fails to package its envelope protein. J. Virol. 73 (1999) 19-28
51. Petit C., Schwartz O., and Mammano F. Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase. J. Virol. 73 (1999) 5079-5088
52. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., and Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72 (1998) 2855-2864
53. Poljak L., Batson S.M., Ficheux D., Roques B.P., Darlix J.L., and Kas E. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins. J. Mol. Biol. 329 (2003) 411-421
54. Rein A., Henderson L.E., and Levin J.G. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 23 (1998) 297-301
55. Rein A., Ott D.E., Mirro J., Arthur L.O., Rice W., and Henderson L.E. Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein. J. Virol. 70 (1996) 4966-4972
56. Rice W.G., Schaeffer C.A., Harten B., Villinger F., South T.L., Summers M.F., Henderson L.E., Bess Jr. J.W., Arthur L.O., McDougal J.S., Orloff S.L., Mendeleyev J., and Kun E. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361 (1993) 473-475
57. Rice W.G., Supko J.G., Malspeis L., Buckheit Jr. R.W., Clanton D., Bu M., Graham L., Schaeffer C.A., Turpin J.A., Domagala J., Gogliotti R., Bader J.P., Halliday S.M., Coren L., Sowder II R.C., Arthur L.O., and Henderson L.E. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270 (1995) 1194-1197
58. Richardson B.A., and Overbaugh J. Basic statistical considerations in virological experiments. J. Virol. 79 (2005) 669-676
59. Rong L., Liang C., Hsu M., Guo X., Roques B.P., and Wainberg M.A. HIV-1 nucleocapsid protein and the secondary structure of the binary complex formed between tRNALys.3 and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription. J. Biol. Chem. 276 (2001) 47725-47732
60. Rong L., Liang C., Hsu M., Kleiman L., Petitjean P., de Rocquigny H., Roques B.P., and Wainberg M.A. Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA. J. Virol. 72 (1998) 9353-9358
61. Rossio J.L., Esser M.T., Suryanarayana K., Schneider D.K., Bess Jr. J.W., Vasquez G.M., Wiltrout T.A., Chertova E., Grimes M.K., Sattentau Q., Arthur L.O., Henderson L.E., and Lifson J.D. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72 (1998) 7992-8001
62. Summers M.F., Henderson L.E., Chance M.R., Bess Jr. J.W., South T.L., Blake P.R., Sagi I., Perez-Alvarado II G., R.C.S., Hare D., and Arthur L.O. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1 (1992) 563-574
63. Tanchou V., Decimo D., Péchoux C., Lener D., Rogemond V., Berthoux L., Ottmann M., and Darlix J.L. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J. Virol. 72 (1998) 4442-4447
64. Thomas J.A., Gagliardi T.D., Alvord W.G., Lubomirski M., Bosche W.J., and Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 353 (2006) 41-51
65. Thomas, J.A., Gorelick, R.J., in press. Nucleocapsid protein function in early infection processes. Virus Res. doi:10.1016/j.virusres.2007.12.006.
66. Topol I.A., McGrath C., Chertova E., Dasenbrock C., Lacourse W.R., Eissenstat M.A., Burt S.K., Henderson L.E., and Casas-Finet J.R. Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: implications for rational drug design. Protein Sci. 10 (2001) 1434-1445
67. Trkola A. HIV-host interactions: vital to the virus and key to its inhibition. Curr. Opin. Microbiol. 7 (2004) 555-559
68. Tummino P.J., Scholten J.D., Harvey P.J., Holler T.P., Maloney L., Gogliotti R., Domagala J., and Hupe D. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 969-973
69. Vogt V.M. Retroviral virions and genomes. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). "Retroviruses" (1997), Cold Spring Harbor Laboratory Press, Plainview, NY 27-69
70. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., and Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46 (2002) 1896-1905
71. Wu W., Henderson L.E., Copeland T.D., Gorelick R.J., Bosche W.J., Rein A., and Levin J.G. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 70 (1996) 7132-7142
72. Zar J.H. Biostatistical Analysis (1999), Prentice Hall, Inc., Upper Saddle River, NJ
73. Zhu K., Dobard C., and Chow S.A. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J. Virol. 78 (2004) 5045-5055